Altered lipid metabolism is an emerging hallmark of cancers. Mirabilite has a therapeutic effect on colorectal cancer (CRC); however, its metabolic mechanism remains unclear. This study aims to explore the potential therapeutic targets of mirabilite protection against colorectal cancer in APC min/+ mice model. Oral administration of mirabilite was started from the ninth month, while the same dosage of distilled water was given to both the control group and the model group. Based on lipidomics, we collected serum samples of all mice at the 20 th week and used a non-targeted method to identify the lipid biomarkers of CRC. Compared with C57BL/6J mice, the metabolic profile of CRC model mice was significantly disturbed, and we identified that 25 lipid-related biomarkers, including linoleic acid, 2-hydroxybutyric acid, 6-deoxocastasterone, hypoxanthine, PC(16:1), PC(18:4), and retinyl acetate, were associated with CRC. According to the abovementioned results, there were six lipid molecules with significant differences that can be used as new targets for handling of CRC through six metabolic pathways, namely, linoleic acid metabolism, retinol metabolism, propanoate metabolism, arachidonic acid metabolism, biosynthesis of unsaturated fatty acids and purine metabolism. Compared with the model group, the metabolic profiles of these disorders tend to recover after treatment. These results indicated that the lipid molecules associated with CRC were regulated by mirabilite. In addition, we identified seven key lipid molecules, of which four had statistical significance. After administration of mirabilite, all disordered metabolic pathways showed different degrees of regulation. In conclusion, high-throughput lipidomics approach revealed mirabilite regulating the altered lipid metabolism as anticancer therapeutics.
Introduction
Colorectal cancer (CRC), one of the most widespread malignant tumors in the world, is the third most commonly diagnosed cancer among people in the US and has increased in morbidity and mortality year by year.
1 CRC usually originates from enteritis, such as inammatory bowel disease and Crohn's disease, 2 and results in cancer in the early to middle and late stages of adenoma. Age, gender, daily lifestyles and diet habits also contribute to the development of cancer.
3 At present, the concealment of the disease course is still a difficult problem for contemporary medical professionals. It is usually discovered in an advanced stage, and the 5 year survival rate has been sharply declined. 4 In clinical practice, serum tumor markers, imaging examinations, and colonoscopy are mainly used to follow-up and check postoperative recurrence of CRC. 5, 6 Moreover, new therapies such as anti-EGFR antibody treatment and bevacizumab and imaging techniques are used to increase the detection rate of metastatic lesions, which can inuence the survival of patients with long-term lesions. 7, 8 However, the sensitivity and specicity of tumor biomarker detection and imaging for screening of recurrent tumors are not ideal, while colonoscopy causes some trauma and cannot be repeatedly used at high frequencies.
Lipids, one of the important nutrients, have many subspecies with physiological functions, such as energy storage, 9 biolm skeleton formation, 10 signal transmission, 11 participation in signal recognition, and immunity. 12 The common feature of cancer progression and metastasis is metabolic reprogramming, such as lipid remodeling that maintains the proliferation of cancer cells. abnormalities in lipid metabolism are associated with the occurrence, development, invasion and metastasis of cancer.
14,15
Traditional Chinese medicine (TCM) has the functions of preventing, treating, diagnosing diseases as well as rehabilitation and improving healthcare. Modern pharmacology studies showed that many types of TCM have the potential function of resisting malignant diseases, and some TCM products, such as paclitaxel, were proved to have anti-tumor effects. 16 Mirabilite, one of purging drugs, has effects on relieving constipation by purgation; moistening dryness and soening; clearing re and detumescence. It is reported that mirabilite has the effect on gastrointestinal diseases such as acute peritonitis, pancreatitis and abdominal pain. 17 However, there is no report for anticancer effect of mirabilite.
Metabolomics is a strong tool to explore metabolite and unlock the biological mysteries by detecting small molecule metabolites with relative molecular weight less than 1000, 18 which provide the investigation of the physiological or pathophysiological intermediate or end-point metabolites under different processes. Based on metabolomics, the metabolic proles given by non-target metabolic analysis platforms can improve our understanding of human disease status. 19 Lipidomics, a part of metabolomics sciences, provide sensitive and accurate analysis of many lipid molecules. In the previous study, we have used the high-throughput lipidomics method to characterize the key lipid molecules as potential therapeutic targets for Alzheimer's disease. 20 UPLC-Q-TOF-MS is considered as one of the powerful tools for representing complex biological samples.
In the current study, we used a sophisticated UPLC-Q-TOF-MS system coupled with multivariate data analysis as well as integrated network analysis to explore the potential lipids in the serum samples of APC min/+ mice. Based on the metabolomics, the system clearly supplied the disturbed serum proles under the condition of CRC and the treatment of mirabilite for 10 weeks, which could deeply explore serum biomarkers called back by mirabilite and elaborate the mechanism of mirabilite acting on APC min/+ mice.
Experiment

Chemical reagents
Mirabilite was obtained from TongRentang Pharmacy (Harbin, China). Both methanol and acetonitrile (UHPLC grade) were bought from Thermo Fisher Scientic (America). Ultrapure water was self-produced (Millipore, Bedford, MA, USA). Formic acid was purchased from Aladdin Reagent Co. Ltd (Shanghai, China). Leucine enkephalin was purchased from St. Louis, USA. Other reagents were of analytical grade.
Animals
The mice were purchased from Nanjing biomedical research institute of Nanjing University (No. 12, Xuefu Road, High-tech Industrial Development Zone, Nanjing, China). The mice acquired were C57BL/6J mice and APC
mice. The animal certicate number of APC min/+ was N000132.
The seven-week-old male mice were transported by air to the laboratory under controlled light conditions to administer food and water freely. Then, we allowed the mice to grow adaptively for two weeks in specic pathogen-free (SPE) conditions. The temperature maintained was 18-20 C and relative humidity was 50-60%. The mice were free to eat and drink in the housing conditions. Next, for the control group, we chose C57BL/6J mice and for the model group and mirabilite-treated group, we randomly used APC min/+ mice. Each group had ve mice (weighting 20 AE 2 g). The mice in the mirabilite group were continuously treated at the dose of 0.1 mL/10 g once per day orally for 10 weeks aer the mice became nine weeks old. Distilled water was given to the mice both in the control group and model group at the same dose per day. The rest of the article will name each group as follows: the control group, the model group and mirabilitetreated groups.
Additionally, we bought ten male ICR mice from safety evaluation center in Heilongjiang university of Chinese medicine and then, we randomly divided the mice into two groups. Five mice were placed in the normal-control group and the other ve mice were placed in the normal-mirabilite treated group with the same dose of mirabilite administered to the mirabilite-treated group every day, and were fed in the same condition of APC min/+ mice for 7 days. The experimental procedures were approved by the Animal Care and Ethics Committee at Heilongjiang University of Chinese Medicine and all experiments were performed in accordance to the declaration of Helsinki.
Sample preparation
Aer administration of mirabilite for 10 weeks, all 15 mice were fasted for 12 hours and then sacriced. Blood samples were collected by picking the eyeball. The serum samples were centrifuged at 4000 rpm for 15 min at 4 C. The supernatant was instantly stored at À80 C. The serum samples were thawed in an ice water bath ahead of UPLC-MS analysis. We absorbed 50 mL serum and added 200 mL methanol in the 1.5 mL Eppendorf microcentrifuge tube to remove macromolecular proteins. Then, we centrifuged the mixture of thawed serum and methanol at 13 000 rpm for 15 minutes at 4 C. The supernatant was transferred to the HPLC vial and kept under cold storage at 4 C.
The preparation of quality control (QC) sample
In order to check the stability and reproducibility of the instrument, we prepared the mixed serum sample of all the serum samples as a QC sample, in accordance with the same procedure. The QC sample provided an interval test for the entire sample sequence. We chose to set up one QC per 5 injections.
Instruments and conditions
An UPLC system was used for the objective analysis of serum samples depending on MassLynx™ 4.1. The chromatography column was C18 Acquity UPLC HSS T3 Column (100 mm Â 2.1, . The injection volume of serum was 2 mL. A was 0.1% formic acid in water and B was 0.1% formic acid in acetonitrile (v/v). Aer injection was completed each time, a needle washing cycle was performed to make sure that the residue was discarded.
Both Waters Acquity TM UPLC liquid chromatographyWaters Synapt TM High Denition MS (HDMS/MS) System and MassLynx V4.1 workstation were chosen to record the chromatogram. The detailed settings were as follows. 
Data processing
As shown in the graphic abstract (GA), we took all the primary UPLC-MS data into the Progenesis QI 1.0 soware for preconditioning (Fig. 1) . The stable and intellective procedure was competent enough to process thousands of data les simultaneously. This procedure contained alignment, normalization, 
Histopathological analysis
We rinsed the intestines with saline and put fresh intestinal tissue in formalin and kept for 24 h. Subsequently, we viewed the tissue histology aer operations such as embedding, slicing, and H&E staining. Then, we used Image pro-plus to analyze the intensity.
Results
Preventive effect of mirabilite on colorectal cancer
Histopathological examination showed that the mice had wellorganized intestinal mucosal structures and intact cells in the control group by the H&E stained method ( Fig. 2A) . However, the bowel gland cells were crowded with the disorganized cellular structure and the partial area had typical hyperplasia, thus causing cancerous change in the model group (Fig. 2B) . In contrast, the intestinal tissue of mice showed regional correction and recovery in the mirabilite-treated group (Fig. 2C) . We collected metabolic proles of serum sample in two groups by full-scan analysis in both ESI + and ESI À (Fig. 3) . Then, we imported the original data column into Progenesis QI, which completed the peak selection and identication. The 2D ion intensity map showed about 9537 ion peaks in ESI + and 10 863 ion peaks in ESI À . Based on the HMDB, 2364 ions in ESI + and 2369 ions in ESI À were matched. Finally, ".usp" les were received by the statistics process. The score plot of PCA responded to the differences between control and model group (Fig. 4) . In the ESI + , we could see that the data were clearly separated between the model and control groups, which suggested that the APC gene was successfully knocked out and the symptoms of CRC were conrmed. The OPLS-DA score plot is shown in Fig. 5(A and B) and the VIP plot is shown in Fig. 5(C  and D) . The VIP plot made great contributions on dataset classication by exploring the different variables.
Identication of potential lipid biomarkers of APC min/+ model
The corresponding VIP plots visually exhibited signicant ion differences between the control and model groups. In addition, VIP > 1 and p < 0.05 were selected as the next analysis target in the current study. Sequentially, the biomarkers were matched by the detailed fragmentation information with Mass Fragment™ application manager based on accurate MS and MS/MS data. Then, through a variety of database searches, such as Lipidomics Gateway, HMDB, and KEGG, the detailed information of compound identication was obtained and listed in the attached table (Table S1 † (Fig. 6 ). The bar graph for relative intensity of biomarkers is shown in the Fig. 7 .
The perturbed lipid metabolic pathways
We obtained six metabolic pathways related to CRC from the MetaboAnalyst 4.0 website. The metabolic pathways were linoleic acid metabolism, retinol metabolism, propanoate metabolism, arachidonic acid metabolism, biosynthesis of unsaturated fatty acids, and purine metabolism, as shown in Fig. 7 , and the one within impact value >0.1 was considered as the important pathways was greater than 0.1 as the focus of our analysis (Table S2 †) . We drew related metabolic pathways of CRC according to the information of potential biomarkers and KEGG (Fig. 8) .
The metabolic prole analysis of mirabilite efficacy
We used supervised variable analysis to obtain PLS-DA scores for control, model, and mirabilite-treatment groups to characterize the pharmacodynamic effects of mirabilite. As shown in Fig. 9 , the control group and the model group were clearly separated. In the negative ion mode, the mirabilite-treated group was between the control group and the model group, and it was closer to the control group, which indicated that mirabilite had a certain regulatory effect on the APC min/+ mice.
However, the results were not very clear in the positive ion mode.
Discovering key lipid molecules from the mirabilite against CRC
From the above results, we can conclude that mirabilite had a certain inuence on transgenic mice. Furthermore, we needed to determine the key biomarkers. The relative peak intensities of biomarkers in control, model and mirabilite-treated groups were listed in the measurement table given by Progenesis QI.
We could see that eleven biomarkers were regulated by 
The inuence of mirabilite in the normal mice
Although mirabilite had a positive effect on the APC min/+ mice, we need to be sure whether mirabilite inuence in the normal mice and the identied biomarkers were specic targets of mirabilite under the condition of disease. Therefore, we designed the experiment to conrm the efficacy of biomarkers for illustrating the mechanism of mirabilite. The distinct biomarkers included 15(S)-HETE, L-acetylcarnitine, PE(18:0/ 0:0), and PE(21:0/0:0), which corresponded with biomarkers of APC min/+ mice. These results suggested that glycerophospholipid metabolism and arachidonic acid metabolism in the normal mice were affected by mirabilite. In contrast, the lipid biomarkers such as linoleic acid, 2-hydroxybutyric acid, 6-deoxocastasterone, hypoxanthine, PC(16:1(9Z)/0:0), PC(18:4(9E,11E,13E, 15E)/0:0), and retinyl acetate were not viewed in the normal-mirabilite treated group. This indicated that these biomarkers were specic biomarkers for efficacy of mirabilite under disease state.
Discussion
In this research, 25 lipid-related biomarkers associated with CRC were identied, which were closely related to the pathogenesis of CRC. The metabolic pathways associated with the serum of APC min/+ were disturbed. Compared with the model group, the metabolic proles of these disorders tend to recover, which was consistent with the control group, indicating that mirabilite inhibited the development of CRC. Moreover, we identied six key lipid molecules, of which four had statistical signicance. Vitamin A (VA), also named retinol, is involved in a variety of physiological and biochemical processes. VA can be obtained from the diet and the dietary retinol ester is converted into retinol in the small intestine or intestinal mucosa, and then esteried to form retinoic acid in the intestinal cells. The original vitamin A is a carotenoid absorbed by mucosal cells, which rst transforms into retinal aldehyde in vivo and then transforms into retinol 21 and enters the blood circulation through lymphatic vessels and stores in the liver. 22 Vitamin A is essential for mucosal immunity 23 and cell differentiation. It is reported that the content of vitamin A is related to the changes in the ecological function of the colon recess, which is closely related to the development of colitis and CRC.
24 APC min/+ mice strain was established based on mutation of adenomatosis polyposis coli (APC) gene in C57BL/6J mice, which has truncation at the 850 th codon of APC. 25 Therefore, the absence of the b-catenin binding domain did not induce the degradation of b-catenin and hence, excess b-catenin transported into the nucleus to promote the tumorigenesis. 26 According to the retinol metabolism on the KEGG website, retinyl acetate can be converted to VA by diacylglycerol O-acyltransferase, and phosphatidylcholineretinol O-acyltransferase and 9-cis-retinal was the downstream metabolite of VA. It is known that b-catenin promoted immune tolerance by inducing VA metabolism via the b-catenin/T-cell factor pathway in dendritic cells, 27, 28 which indicated that VA metabolism was important to the CRC. In the current study, the retinyl acetate and 9-cis retro-g-retinal were signicantly different in the control and model groups, and both of them were called back aer the administration of mirabilite. These results illustrated that oral mirabilite may improve immune function in APC min/+ mice.
Based on the abovementioned results, we can summarize that LysoPC compounds disordered in the model group, and most of the LysoPC compounds had been returned to normal levels by the treatment of mirabilite. These metabolites belonged to glycerophospholipid metabolism, which has strong hemolytic effects. Lipid metabolism involved the regulation of many cellular processes such as cell growth, proliferation, differentiation, inammation, chemotherapeutic response and drug resistance. [29] [30] [31] [32] [33] [34] [35] [36] Moreover, lipid metabolism was regulated by multiple signaling pathways and produced a variety of bioactive lipid molecules associated with the activation or regulation of different signaling pathways, such as fatty acids, phosphatidic acid, lysophosphatidic acid, ceramides, sphingosine and cholesterol. 37, 38 It is known that lipid metabolism is merely related to CRC. 39 It has been shown that more LDs exist in the CRC cells than the normal counterpart, 40 which would be the target of CRC.
41
Abnormal expression of lipid metabolism in mice of the model group suggested that the energy metabolism was disordered and tumor proliferation was accelerated. 42 This also reects the state of the mucosal barrier and the intestinal permeability. 43 Aer administration of mirabilite, some of the lipid metabolites reverted, such as PC(16:1(9Z)/0:0), PC(18:4(9E,11E,13E,15E)/0:0), PE(18:0/0:0), and PE(21:0/0:0). These results indicated that the CRC progression of the treated mice was inhibited. Propanoate metabolism was found to be another pathway regulated by mirabilite in this study. Propionic acid, one of short-chain fatty acids (SCFA), can be absorbed to decrease the risk of cardiovascular disease.
44
Intestinal short-chain fatty acids are involved in the energy supply of intestinal epithelial cells and can affect the pH and electrolyte balance in the intestinal lumen, the permeability of the intestinal mucosal barrier as well as the regulation of intestinal motility, anti-inammatory and anti-tumor effects etc. 45 Global metabolomics opens up new avenues for biomarker discovery. Lipidomics proling can provide an innovative tool for better understanding the disease mechanisms and can also be used to discover the lipid molecules as potential therapeutic targets for disease.
46-57
Conclusions
In the current study, we used a high-throughput UPLC-Q-TOF-MS technology to nd potential lipid biomarkers in APC min/+ mice based on the lipidomics. Ultimately, we obtained 25 potential biomarkers. In addition, we found six perturbed pathways of CRC, namely, linoleic acid metabolism, retinol metabolism, propanoate metabolism, arachidonic acid metabolism, biosynthesis of unsaturated fatty acids, and purine metabolism, which also reected different degrees of callback aer oral administration. In addition, six lipids molecules might be potential targets for mirabilite's treatment of CRC. This study revealed that mirabilite could achieve anticancer effects by regulating changes in lipid metabolism.
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